QRT-PCR and WB analysis showed that the expression level of VEGF in CM-treated bladder cancer cells increased, indicating that CM can induce angiogenesis by promoting the secretion of VEGF in bladder cancer cells. This evidence concerns the gene VEGFA and urinary bladder cancer.